Effect of orlistat on periostin, adiponectin, inflammatory markers and ultrasound grades of fatty liver in obese NAFLD patients

Orlistat is recommended in the treatment of obesity, which is an independent risk factor for nonalcoholic fatty liver disease (NAFLD). The reported findings of orlistat in NAFLD are divisive. Recently, periostin is identified as an important regulatory molecule in the pathogenesis of obesity-induced...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali Khan, Rashid, Kapur, Prem, Jain, Abhinav, Farah, Farrukh, Bhandari, Uma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328128/
https://www.ncbi.nlm.nih.gov/pubmed/28260907
http://dx.doi.org/10.2147/TCRM.S124621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328128/
https://www.ncbi.nlm.nih.gov/pubmed/28260907
http://dx.doi.org/10.2147/TCRM.S124621

Ejemplares similares